| India | Turkey | Austria | |
| Sarcoma surgery | from $7,500 | from $10,000 | from $35,000 |
| Radiation therapy for colorectal cancer | from $3,200 | from $7,000 | from $12,000 |
| Radiation Therapy for Sarcomas | from $4,500 | from $3,250 | from $18,000 |
| Complex treatment of Ewing's sarcoma | from $22,000 | from $30,000 | from $55,000 |
| Chemotherapy for breast cancer | from $3,500 | from $1,200 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Ewing's sarcoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ewing's sarcoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ewing's sarcoma treatment journey.
Dr. Shruti Kate specializes in Ewing's sarcoma with expertise in immunotherapy and metronomic therapy for advanced cancers. She trained at Tata Memorial Hospital, a leading cancer center.
Pediatric hematologist-oncologist Dr. Kharya specializes in bone marrow transplants for childhood cancers at Artemis Hospitals.
Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre. He specializes in breast and thoracic surgical oncology. Dr. Nagarkar trained at the prestigious Tata Memorial Hospital in Mumbai. He is a Member of the Royal College of Surgeons in Edinburgh.
The doctor is a pediatric hematologist-oncologist with a specialization in bone marrow transplantation. They have extensive experience in treating complex blood disorders and cancers in children. Their clinical focus includes the management of pediatric leukemia, lymphoma, and other hematologic malignancies. The doctor is recognized for their expertise in performing bone marrow transplants and has contributed to advancements in pediatric oncology through clinical research and innovation.
Indian oncologists possess significant experience treating Ewing sarcoma through specialized musculoskeletal departments. Accredited facilities utilize multidisciplinary tumor boards to manage these rare bone tumors. Large-scale institutions often treat high volumes of cases. This expertise facilitates precise surgical resection and advanced radiation protocols.
Bookimed Expert Insight: Patient volume is a primary indicator of expertise in India. HCG Manavata Cancer Centre and Global Hospital Chennai collectively treat over 150,000 patients annually. This massive scale allows doctors like Dr. Shruti Kate to specialize deeply in pediatric malignancies. Choosing a high-volume center ensures your team has managed multiple Ewing cases recently.
Patient Consensus: Patients note that seeking a specialized sarcoma team is more effective than consulting a general oncologist. They emphasize that outcomes improve when pediatric experts coordinate care for the adolescents typically affected by this tumor.
Bookimed Expert Insight: Patients can access specialized expertise at centers like HCG Manavata Cancer Centre, which features over 40 consultant oncologists. This high concentration of specialists is vital because Dr. Shruti Kate and other practitioners at such institutions often hold advanced DM Medical Oncology degrees from top tier institutions like Tata Memorial Hospital. Choosing a facility that treats over 75,000 patients annually ensures the surgical team has extensive experience with complex bone resections and reconstructions.
Patient Consensus: Patients emphasize the importance of starting with chemotherapy to shrink large tumors before surgery. Many note that choosing a center with an orthopedic oncologist is essential for maximizing the chances of successful limb-sparing results.
Indian oncology centers report a 5-year survival rate between 60% and 75% for localized Ewing's sarcoma. Specialized pediatric facilities like Fortis Gurgaon and Manipal Hospitals utilize multi-modality protocols. Success depends on achieving a 100% complete protocol response through chemotherapy and surgery.
Bookimed Expert Insight: Patient volume is a major quality signal in India. Manipal Hospitals and Global Hospital Chennai each serve 2,000,000 patients annually. Large tertiary centers maintain higher success rates because they integrate pediatric oncology with advanced orthopedic surgery. Choosing these high-volume facilities ensures access to specialists like Dr. Shruti Kate, who are trained at premier institutions like Tata Memorial Hospital.
Patient Consensus: Getting a clear diagnosis before the tumor grows beyond 8 cm is vital. Patients emphasize that finishing every chemotherapy cycle without delay is the most important factor for a cure.
Limb-salvage surgery is a viable alternative to amputation for most Ewing's sarcoma cases in India. Surgeons remove the tumor while preserving the limb's nerves and blood vessels. This procedure requires clear margins and adequate bone for successful reconstruction and natural function.
Bookimed Expert Insight: Patient data shows that second opinions in India often shift treatment from amputation to salvage. Major facilities like Global Hospital Chennai and Manipal Hospitals handle millions of patients annually. These high-volume centers provide the multidisciplinary teams needed for complex bone resections. Choosing a facility with both orthopedic oncology and advanced radiation therapy is vital for success.
Patient Consensus: Patients note that seeking a dedicated sarcoma team early is essential. They often emphasize that recovery requires long-term rehabilitation and patience with potential hardware complications.
Long-term side effects of Ewing's sarcoma treatment include cardiac strain, potential infertility, and bone growth issues. Families must prepare for ongoing cardiac monitoring and physical rehabilitation. Pediatric survivors may experience limb-length discrepancies or scoliosis. Secondary malignancies and emotional distress like scan-related anxiety are also significant concerns.
Bookimed Expert Insight: Data from major Indian centers like Manipal Hospitals and Fortis Gurgaon shows a heavy focus on multidisciplinary care. Choosing a facility with both pediatric oncology and advanced orthopedics is vital. Centers like Global Hospital Chennai, which handle 80,000+ patients annually, often provide the specialized rehabilitation needed for bone resections. Always ask if your chosen hospital includes long-term survivorship monitoring in their post-treatment protocols.
Patient Consensus: Families emphasize that the need for physiotherapy continues for years after the final scan. Many express a deep wish they had discussed fertility freezing options before the very first dose of chemotherapy.
Patients seeking Ewing's sarcoma treatment in India can access government schemes like Ayushman Bharat (PM-JAY) and state-specific relief funds. Many NABH-accredited facilities offer financial aid or charity beds. Eligibility usually depends on income status, age, and specific medical documentation provided during the hospital admission process.
Bookimed Expert Insight: Patient volume is a major indicator of a facility's ability to navigate complex funding. Manipal Hospitals serves 2,000,000 patients annually, while HCG Manavata treats over 75,000. These high-volume centers typically have dedicated social work departments. They are more experienced in processing state schemes and managing documentation for high-cost Ewing's sarcoma protocols.
Patient Consensus: Patients emphasize the need to ask about cashless treatment options on day one. Families often combine government insurance with local fundraising and NGO grants to cover the entire course of therapy.
Indian oncology centres report a 70% to 80% five-year survival rate for localised Ewing sarcoma. Success depends on early diagnosis and multidisciplinary care. For metastatic cases, survival typically ranges between 30% and 50%. Specialists use a combination of chemotherapy, precision surgery, and radiotherapy.
Bookimed Expert Insight: Success in India often hinges on hospital technology rather than just surgical skill. Facilities like Fortis Gurgaon rank among the world's most technically advanced hospitals. They integrate robotic surgery and digital imaging to improve margins during bone resection. This technological edge helps maintain survival rates comparable to global benchmarks.
Patient Consensus: Patients in India report positive long-term outcomes. Some remain cancer-free years after completing intensive 14-cycle chemotherapy regimens. They highlight the value of seeking dedicated paediatric sarcoma specialists for personalised care plans.
Surgeons in India achieve limb salvage in over 90% of Ewing's sarcoma cases. They remove the tumour while preserving the limb's structure and function. Reconstruction uses metallic prostheses or bone grafts. Pre-surgery chemotherapy often shrinks tumours to make preservation possible.
Bookimed Expert Insight: Indian oncology centres often provide survival rates comparable to Western facilities at lower costs. For example, Global Hospital Mumbai reports costs 30% to 50% lower than Europe. Higher patient volumes at these centres allow surgeons to maintain proficiency in complex limb-sparing techniques.
Patient Consensus: Patients emphasise that limb-sparing surgery remains the preferred approach in India. They note that choosing orthopaedic oncologists who specialise in bone regeneration or prosthetics is critical. This is key for long-term mobility and recovery.
Ewing's sarcoma treatment in India typically spans 9 to 12 months. This intensive timeline covers 14 to 16 cycles of chemotherapy, surgery, and potential radiation. Most patients remain in India for roughly three quarters of a year. This allows them to complete the full multi-modal protocol.
Bookimed Expert Insight: Many expect treatment to finish after surgery. However, Indian academic centres like HCG Manavata apply extended consolidation chemotherapy. Their data shows over 65,000 cancer surgeries performed, often integrated into a 51-week protocol. This long-term approach prevents recurrence but requires a year-long commitment in India.
Patient Consensus: Patients note that treatment cannot be fast-tracked. This is because the body needs 3 weeks between cycles to recover. High-calorie diets are often recommended by Indian specialists. This helps survivors maintain strength during the 14-cycle journey.